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Abstract: The 
17O nucleus has been used recently by several groups for magnetic resonance (MR) imaging of cerebral 
metabolism. Inhalational delivery of 
17O2 in very brief pulses could, in theory, have significant advantages for 
determination of the cerebral metabolic rate for oxygen (CMRO2) with MR imaging. Mechanical ventilators, however, are 
not typically capable of creating step changes in gas concentration at the airway. We designed a ventilator for large animal 
and human studies that provides mechanical ventilation to a subject inside an MR scanner through 25 feet of small-bore 
connecting tubing, and tested its capabilities using helium as a surrogate for 
17O2. After switching the source gas from 
oxygen to helium, the 0-90% response time for helium concentration changes at the airway was 2.4 seconds. The 
capability for creating rapid step changes in gas concentration at the airway in large animal and human studies should 
facilitate the experimental testing of the delivery 
17O2 in brief pulses, and its potential use in imaging CMRO2. 
INTRODUCTION 
 
17O is a stable isotope of oxygen that has been used in 
several recent studies for magnetic resonance imaging (MRI) 
of the cerebral metabolic rate of oxygen utilization (CMRO2) 
[1-8]. Prior studies have delivered gaseous 
17O2 by inhalation 
for a period ranging from 2 minutes [9] to 40 minutes [5]. 
Delivery of 
17O2 in very brief (less than 2 minutes) pulses 
could, in theory, provide significant advantages for imaging 
of CMRO2, but mechanical ventilators for large animals and 
humans are not typically designed to provide rapid step 
changes in gas concentration at the airway. Modern, servo-
controlled, open-circuit ventilators that are commonly used 
in the intensive care unit can provide a change in inspired 
gas concentration with a time constant of a few seconds [10, 
11]. The use of an open-circuit ventilator, however, would 
lead to tremendous waste of 
17O2 gas, currently priced at 
approximately $2000/liter for a 40% enrichment fraction. 
Closed-circuit and low flow, semi-closed systems for 
mechanical ventilation are designed to conserve 
administered gases such as inhaled anesthetics. These 
systems, however, have time constants for changes in gas 
concentrations at the airway that are on the order of a few 
minutes [12]. We designed and tested a mechanical 
ventilator specifically developed to produce rapid gas 
concentration changes at the airway through long runs of 
tubing between the ventilator mechanical parts outside an 
MRI scanner and a subject inside the scanner.  
Rationale for Delivery of 
17O2 in Brief Pulses 
 
17O incorporated into water, H2
17O, produces an MR 
signal, but gaseous 
17O2 does not [2]. MR imaging with 
17O  
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therefore provides a way to image metabolically produced 
water, H2
17O, without any need to account for concurrent 
changes in 
17O2. Ideally, CMRO2 could be calculated from a 
local signal that is a simple function of the water produced 
locally in the mitochondria. Some of this metabolically 
produced H2
17O, however, leaves the region of interest (ROI) 
by diffusing to the venous circulation. Additionally, water 
produced outside the ROI also diffuses to its venous 
circulation, and re-circulates into the ROI in the arterial 
blood. The changes in H2
17O in the ROI, therefore, are 
related not only to CMRO2, but also to cerebral blood flow 
(CBF), and to the arterial input function for H2
17O [2]. Zhu et 
al. [2] have presented a comprehensive model of the 
relationship between local concentration of H2
17O and 
CMRO2, based on the mass balance principles first 
developed by Kety and Schmidt [13]: 
…         (1) 
where Cb(t) is the local concentration of H2
17O in excess of 
natural abundance,  is the 
17O enrichment fraction of the 
inhaled 
17O2 gas (treated as a constant for long 
administration times), CBF is cerebral blood flow, Ca(t) and 
Cv(t) are the concentrations of H2
17O in excess of natural 
abundance for arterial and venous blood, and f1 and f2 are 
unit conversion factors.  
  Delivery of a very brief pulse of 
17O2 could potentially 
simplify the relationship between locally measured H2
17O 
and CMRO2. Immediately after a breath of 
17O2, the water 
that is produced outside the ROI should be delayed in its 
entry into the ROI, as it must diffuse to the local venous 
circulation and transit through the heart and lungs before 
entering the arterial circulation. The venous-arterial 
convection delay for an adult human is typically on the order 
of 10-15 seconds [14]. For a brief period immediately after 
beginning inhalation of 
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function of H2
17O should be zero, which would eliminate the 
Ca(t) term in equation (1). In contrast, the local production 
of H2
17O should commence almost immediately, as the 
expected diffusion lag for 
17O2 can be estimated to be less 
than one second. This diffusion time lag is characterized by 
the time constant 
2/D, the average diffusing distance 
squared divided by the diffusivity of oxygen in tissue [15]. 
For an average capillary spacing in brain of 50 microns [16], 
each capillary can be estimated to supply a cylinder of radius 
25 microns. The spatially averaged diffusing distance, 
assuming uniform distribution of mitochondria around the 
capillary, is then estimated at 17 microns. For a simple one-
dimensional diffusion model into a finite slab, solution to the 
transient diffusion equation [15] with an oxygen diffusivity 
in tissue of 2.4 x 10
-5 cm
2/sec [17] estimates that the average 
0-90% rise time in mitochondrial concentration after a step 
change in arterial concentration would be approximately 130 
msec. This diffusion delay in mitochondrial 
17O2 utilization 
can therefore be neglected for all but the shortest arterial 
pulses. 
  Additionally, because water movement through lipid 
bilayers tends to be restricted [18], locally produced water 
may be delayed in its egress to the venous circulation as it 
passes through the mitochondrial, the plasma, and the 
capillary endothelial membranes [2]. A diffusional delay in 
non-cerebral tissues would further extend the period of a 
negligible arterial input function. Additionally, substantially 
restricted diffusion of water from mitochondria to the venous 
circulation within the ROI would minimize the Cv(t) term in 
equation (1). For a brief period after initiating a pulse of 
17O2 
delivery, then, the relationship between H2
17O concentration 
and CMRO2 should approximately obey the simplified 
relationship: 
…           (2) 
where k1 is a conversion constant, and Ca
17O2(t) is the time-
dependent arterial 
17O2 concentration. The constant  of 
equation (1) has been replaced in equation (2) by Ca
17O2(t) 
because the kinetics of alveolar gas dilution cannot be 
neglected for brief pulses of 
17O2 (appendix).  
  Prior studies in small animals have used a simplified 
equation, similar to equation (2) with no arterial input and no 
venous washout terms, to successfully estimate CMRO2 after 
inhaling 
17O2  [8, 19-21]. For large animals and humans, 
however, the length of this brief period of negligible arterial 
H2
17O input function, the quantitative importance of 
restricted water diffusion, and the time window in which 
equation (2) represents a useful approximation, remain to be 
determined. Experimental testing of these theoretical 
advantages would be greatly facilitated by a ventilator 
capable of delivering sharp step changes in gas concentration 
at the airway.  
Design Criteria for the New Mechanical Ventilator 
  The main design consideration for the ventilator was the 
goal to produce sharp step changes in gas concentration at 
the airway. This dictated avoidance of any sudden transitions 
in diameter of the gas flow pathway (such as conventional 
one-way valves), which could slur a sharp gas concentration 
front. This also dictated that the inspiratory limb tubing be of 
the smallest diameter feasible, reducing transit time from the 
gas source to the airway and minimizing diffusive mixing 
between sharp concentration boundaries.  
  Some design constraints were imposed by the goal 
ultimately to apply this ventilator to functional imaging 
studies, where it is desirable to avoid stimulatory cues. For 
this reason, use of gas switching valves near the subject in 
the scanner was restricted, which in turn means that the gas 
switching valves and all mechanical devices would ideally 
be outside of the scanner. This in turn required atypically 
long tubing runs, placing an even greater premium on 
narrow-bore tubing.  
  Some design constraints were imposed by the expense of 
17O2 gas. Delivery of the gas in very brief pulses has a 
natural advantage of minimal gas use per CMRO2 
measurement. In addition, however, it is desirable to recover 
as much of the unused gas in the exhaled breaths as possible, 
making it advantageous to have a gas selection valve to 
direct the exhaled gas to recovery versus waste, with 
precisely controlled timing to select segments of exhaled gas 
with the highest 
17O2 concentrations. Maximal recovery of 
exhaled 
17O2 also dictates that the diameter of the exhalation 
tubing should be small, again to avoid diffusive slurring of 
concentration fronts. Additionally, from a financial 
perspective, it was considered desirable for the ventilator to 
be capable of pressurizing 
17O2 mixtures from un-pressurized 
sample bags rather than pressurized gas cylinders, thereby 
avoiding costly mistakes in gas handling that might occur in 
the early developmental stages.  
  Finally, in the interests of versatility, it was decided that 
the ventilator should be capable of either comfortable, 
supported spontaneous ventilation in awake subjects; or 
controlled mechanical ventilation in anesthetized subjects.  
MATERIALS AND METHODS  
  The system for mechanical ventilation appears 
schematically in Fig. (1). Gases are pumped to and from the 
subject by two large peristaltic pumps (Cole-Parmer
®, 
Chicago IL; Masterflex
® I/P digital drive with dual standard 
pump heads and silicone I/P 73 tubing), one for assisting or 
controlling inhalation (“PPi” in Fig. 1), and one for assisting 
or controlling exhalation (“PPe”). The pumps outside of the 
MRI scanner are connected to the subject inside the scanner 
by 25 feet of 0.25 inch ID Tygon
® tubing (Cole-Parmer
® L/S 
17). At the maximum flow provided by the pumps of 16 
L/min, the Reynolds number for pure oxygen is 3800, i.e. the 
flow is in the turbulent range at the maximal volumetric flow 
rate. At this maximal flow rate, the transit time for 25 feet of 
the 0.25 inch ID tubing is 0.90 seconds. The pressure drop 
across the transit tubing for maximal flow is 12 cm H2O, 
which is over 100 fold less than the maximal operating range 
of the peristaltic pump. Pressure at the subject’s airway 
(“Paw”) is transmitted by 0.125 inch ID nylon tubing to a 
pressure transducer (Freescale Semiconductor, Chandler, 
AZ, MPX2010DP) with signal amplification by a custom op-
amp circuit. Information on airway pressure is transmitted 
via  a multifunction DAQ device (National Instruments™, 
Austin TX, USB-6008) to a computer that uses feedback 
control to adjust the pump speeds for both pumps during 
assisted spontaneous ventilation and for the exhalation pump 
during volume-controlled mechanical ventilation. Inhaled Mechanical Ventilator for Delivery of 
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gases can be chosen via a computer controlled stream select 
valve (“inh”) (VICI
® Valco Instruments, Houston, TX, 
Model C45) to select air, regular 100% O2, oxygen with 
enriched 
17O2, or other test gases. The oxygen and test gases 
are sealed in Tedlar
® gas sampling bags (Cole-Parmer
®). 
Exhaled air can be directed, via a second stream select valve 
(“exh”), to either waste (“W”), or to recovery of the partially 
enriched 
17O2. All data acquisition and control software was 
written in Labview 7.1 (National Instruments™, Austin TX).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Schematic diagram of the system for mechanical 
ventilation. 
 
  The long tubing connections between the mechanical 
components and the subject required a significant departure 
from prior approaches to mechanical ventilation. Although a 
wide variety of ventilator modes are available from 
conventional ventilators, exhalation is almost universally 
passive, i.e. the exhalation pressure at the ventilator is set to 
a prescribed value and the lungs exhale passively against that 
exhalation pressure. Ventilator exhalation tubing is usually 
sized in a large enough diameter to make expiratory flow 
resistance negligible, thus keeping the pressure at the airway 
equivalent to the set exhalation pressure in the ventilator. For 
the system constructed here, large bore exhalation tubing 
would greatly increase the circuit priming volume, and 
would also tend to slur any sharp concentration fronts in the 
exhalation limb, making clean recovery of partially enriched 
17O2 more difficult. Passive exhalation, therefore, leads to 
design requirements for the exhalation tubing that are 
fundamentally at odds with the desire for efficient use and 
recovery of the expensive 
17O2 gas. The system depicted in 
Fig. (1) approaches these problems by actively assisting 
exhalation as well as inhalation. Pressure at the airway is 
monitored and fed back to the control system, which then 
adjusts the exhalation pump speed. The target exhalation 
pressure at the airway can then be specified at any given 
level, and for the subject it feels as though he or she is 
exhaling passively at that pressure, even though the pressure 
required at the end of the exhalation tubing varies markedly 
according to the expiratory flow rate. 
  At the inspiratory side, mechanical ventilators typically 
have either a gas bellows, or a piston and cylinder, both of 
which can slur rapid step changes in gas concentration [22], 
and both of which increase the circuit priming volume. We 
used an additional roller pump here which eliminates the 
reservoir volume and also avoids any large sudden changes 
in tubing diameter, helping to preserve step changes in gas 
concentration. 
  Control of the pumps was implemented with a sequential 
state machine, with a single inspiration state and a single 
expiration state for each breath. Within each state, the 
opposing pump was stopped and the appropriate pump for 
the state (for example the inhalation pump for the inspiration 
state) was controlled according to the airway pressure with 
simple proportional control. For transitioning between states, 
awake subjects were instructed to initiate inspiration by 
transiently (5 msec) reducing airway pressure below a 
critical value (-33 cm water) and then to inhale as normally 
as possible. Transition to the expiration state was signaled by 
a transient (5 msec) increase of airway pressure above a 
critical value (33 cm water). For safety, the awake subjects 
manually held a breathing mask to their faces for a tight seal 
and were instructed to remove the mask if breathing became 
uncomfortable.  
  For use in large anesthetized animals, we also 
implemented a much simpler algorithm for volume 
controlled ventilation. Transitions between the states were 
strictly determined by the inspiratory and expiratory times, 
as determined by the desired respiratory rate and 
inspiratory/expiratory ratio. For example, a respiratory rate 
of 10 breaths/min and an I:E ratio of 1:2 entered by the user 
would translate to an inspiratory time of 2 seconds and an 
expiratory time of 4 seconds. Inhalation pump speed was 
accelerated to a constant value, determined by the desired 
tidal volume, that was maintained throughout the inspiratory 
time. Exhalation pump speed during the expiratory state was 
again controlled according to airway pressure. 
  With Institutional Review Board approval, the system for 
mechanical ventilation was tested in a sitting human 
volunteer in spontaneous ventilation mode, with use of 
helium as a surrogate for 
17O2, and with monitoring of gas 
concentrations at the airway with a micropore membrane 
inlet respiratory mass spectrometer [23]. The time response 
of the mass spectrometer was determined by placing the 
sample port in a stream of flowing gas, directly downstream 
of a switching valve (Valco Instruments Model C45), and 
switching the gas source from 0% to 100% helium. The 
subject breathed through the circuit in assisted spontaneous 
ventilation mode, where both inspiratory and expiratory 
pump flows were controlled by the pressures generated at the 
airway by the subject. After switching to 100% O2 and de-
nitrogenation, the inhalation valve was switched to a source 
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the airway was recorded by the mass spectrometer. After two 
inhaled breaths of helium, the source valve was switched 
back to 100% oxygen. Exhaled gas was directed, by the 
exhalation valve, to the ‘recovered 
17O2’ gas sampling bag 
for these two breaths of helium and for the following breath. 
Helium concentration in the ‘recovered 
17O2’ bag was then 
measured with the respiratory mass spectrometer. 
RESULTS 
  Acceleration to full speed from a full stop for the pumps 
of Fig. (1) was well described by a mono-exponential time 
constant of 0.88 sec. Similarly, deceleration was well 
described by mono-exponential decay with a time constant 
of 1.46 seconds. The inhalation and exhalation pump flow 
changes in response to changes in airway pressure were 
adequate to provide subjectively comfortable spontaneous 
breathing in the normal human subject.  
  The 0-90% response time of the respiratory mass 
spectrometer was 2.2 seconds (Fig. 2). The step change in 
gas concentration at the airway provided by the ventilator 
circuit was fast enough to approach the temporal resolution 
of the mass spectrometer, with a measured 0-90% response 
time of 4.0 seconds (Fig. 2). After correction for the mass 
spectrometer time response by de-convolution, the estimated 
0-90% response time at the airway was 2.4 seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Time responses after a step change in gas concentration for 
the mass spectrometer (solid circles); and the complete ventilator 
circuit (open circles). 
 
  The time course of helium concentration changes at the 
airway during two breaths of helium are shown in Fig. (3), 
with labeling of the phases of the respiratory cycle. The 
measured end-tidal helium concentration after a single deep 
breath was 41%.  
  After further practice by the subject breathing as deeply 
as possible with the ventilator system, the end-tidal helium 
after a single deep breath was 48%. For the idealized 
scenario of a perfect step change in gas concentration in a 
healthy individual breathing through an apparatus of 
negligible resistance, the maximum end tidal helium 
concentration predicted from standard pulmonary function 
testing (PFT) nomograms [24, 25] is 68%, with a 
conservative estimate (based on +/- one STDV for a 
coefficient of variation of 20%) of the range of normal 
values around this mean extending from 54% to 82%. Thus, 
achieving an end-tidal concentration of up to 48% in one 
individual after a single breath of helium indicates that the 
ventilator circuit is able to provide a change in gas 
concentration in the lung that is approaching the theoretical 
maximum, despite providing this breath of helium through 
25 feet of narrow bore tubing. The measured concentration 
of helium in the ‘recovered 
17O2’ gas sampling bag was 47%, 
which compares favorably with the maximum possible 
recovered concentration of 49%. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Helium concentration at the airway for two breaths of 
100% helium after equilibration with 100% oxygen. 
 
DISCUSSION 
  The ventilator we designed and tested is capable of 
delivering step changes in gas concentration at the airway 
through long runs of narrow bore tubing between the 
mechanical pumps of the ventilator and a subject in the MR 
scanner. After this step change at the airway, the kinetics of 
17O2 uptake into arterial blood (the term Ca
17O2(t) in 
Equation (2)) should be easily predicted by mathematical 
models (appendix) [26]. A crucial remaining issue for the 
use of very brief pulses of 
17O2 for CMRO2 measurement is 
the length of the time window for which equation (2) 
applies. The delay in the appearance of H2
17O owing to 
convection from the venous circulation to the arterial 
circulation is expected to be on the order of 10-15 seconds 
[14]. Diffusive delays from the mitochondria to the venules 
would add to this convective delay, but estimation of the 
diffusive delay from either theory or prior experimental data 
is difficult. Previous studies have almost universally 
assumed instantaneous equilibration between the tissue 
compartment and the vascular compartment, an assumption 
implicit in the use of Kety-Schmidt type well-mixed 
compartments. To our knowledge, however, there is 
currently no definitive experimental data to support the 
assumption of complete equilibration. From a theoretical 
perspective, it is known that water diffusion through lipid 
membranes is highly restricted in the absence of aquaporins 
[18]. It has also been recently reported that some tissues 
have abundant aquaporins to facilitate trans-membrane water 
transfer (for example, renal tissues [27]). In contrast, no 
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aquaporins have been found in other tissues, notably the 
majority of cerebral neurons [28]. The possibility that some 
tissues may in fact approximate the well-mixed model and 
have zero diffusional delay, whereas others may have 
substantial diffusional delay, suggests that the arterial input 
function might best be determined experimentally.  
  The limited experimental data that has been reported 
previously on this topic suggests that the arterial input 
function may be delayed beyond the expected convection 
delay. Zhu and coworkers, in a study presented in abstract 
form in 2002 and discussed in their 2005 review [2], showed 
in rats that cerebral washout of H2
17O after a bolus arterial 
injection was faster than washout after cessation of 
17O2 
breathing, implying at least qualitatively that diffusion from 
the mitochondria to the venous circulation is restricted in the 
brain. Pekar and coworkers [3] measured the increase in 
arterial H2
17O every 30 seconds after the initiation of inhaled 
17O2, in cats, and estimated a delay in the increase in H2
17O 
on the order of 30-60 seconds, which exceeds the expected 
convective delay in these small animals. Mintun et al. 
measured the arterial input function of metabolically 
generated water in adult humans using PET techniques 
applied to 
15O isotopes [29]. They reported a peak in the 
arterial H2
15O that lagged the peak in O
15O by approximately 
70 seconds, which suggests that there are at least some 
tissues contributing to the H2
150 peak that had considerable 
diffusional delay. The availability of the new mechanical 
ventilator reported here should facilitate additional 
experimental studies on this issue using 
17O2 and either MR 
measurements of H2
17O in timed arterial blood samples, or in 
imaging of large arterial vascular structures in large animals 
or humans.  
  This new mechanical ventilator should also be useful in 
assessing the delay in cerebral venous washout of 
metabolically generated water due to restricted diffusion. In 
this situation also, predictions of the equilibrium between 
tissue and venous blood on theoretical grounds is difficult. It 
is certainly expected that water diffusion through the series 
of membranes from the mitochondria to the venous 
circulation (the mitochondrial inner and outer membranes, 
the plasma membrane, and the endothelial cell membranes) 
is diffusionally restricted [18], especially since the cerebral 
neurons appear to have limited aquaporins [28]. Predicting 
the quantitative importance of this restricted diffusion for a 
realistic three dimensional geometry, however, is 
challenging. The time window during which equation (2) 
applies might therefore best be determined experimentally. 
The ability to deliver 
17O2 in a brief pulse should facilitate 
this determination, either by timed cerebral venous blood 
sample collection and MR analysis of H2
17O concentrations, 
or by imaging of cerebral venous structures after delivery of 
a brief pulse by the ventilator.  
  After defining the time window for which equation (2) 
represents a reasonable approximation, the substantial 
remaining challenge in exploring the measurement of 
CMRO2 using brief pulses of 
17O2 is the acquisition of 
images, within this narrow time window, with an adequate 
signal to noise ratio (SNR). This new ventilator has already 
proved useful in studies exploring new fast imaging 
techniques to improve SNR [30], and we anticipate that it 
will be advantageous in further studies in this area.  
APPENDIX 
  After a step change in gas concentration at the airway, 
the dominant factor in the time course of alveolar and arterial 
17O2 uptake is the kinetics of gas dilution in the alveoli, as 
the tidal ventilation mixes with residual gas in the lung. The 
time course of arterial 
17O2 concentration (Ca
17O2(t) in 
equation 2) can be estimated from a mathematical model 
based on established principles of alveolar gas mixing [26]. 
In the general case, the estimation can be obtained easily 
with the evaluation of 2 integrals. In the particular case of 
volume controlled ventilation in a large anesthetized animal, 
with fixed inspiratory concentration and constant inspiratory 
flow, the integrals reduce to a simple algebraic equation for 
alveolar 
17O2 concentration that can be applied recursively to 
estimate the arterial 
17O2 input function over several breaths.  
  At end-exhalation, the lung is filled with a residual 
alveolar volume as well as deadspace volume in the airways. 
During the first part of inspiration, the deadspace gas re-
enters the alveolus with no change in alveolar gas 
concentration. It is assumed as an approximation that the 
inspired gas/deadspace gas interface is transmitted to the 
alveolus as a sharp step change in concentration. At the 
moment this concentration front is entering the alveolus, the 
alveolar gas volume is the end-exhalation volume plus 
deadspace volume, at the end-exhalation gas concentration. 
From this point forward, the total amount of 
17O2 in the 
alveolar space, Y(t), at time t is given by: 
         (A1) 
where PET is the end-tidal 
17O2 partial pressure at the last 
exhalation, Vee is the end-expiratory volume, Vd is the 
deadspace volume, dV/dt is the flow rate as a function of 
time, and Pi(t) is the inspired 
17O2 partial pressure as a 
function of time. The total alveolar gas volume, X(t), as a 
function of time is given by: 
           (A2) 
  The alveolar gas partial pressure versus time during 
inhalation is then simply Y(t)/X(t). For the large tidal 
volumes typically used experimentally, the delivery of 
17O2 
in each breath far exceeds the gas volume taken up by blood, 
and to a first order blood uptake can be neglected. 
  The ventilator system presents a fixed 
17O2 partial 
pressure Pi(t) throughout inspiration. The deadspace volume 
Vd and the residual volume at end expiration Vee can be 
estimated from standard nomograms [24, 25]. Flow rate as a 
function of time (dV/dt) is known from the relationship 
between inspiratory pump speed (recorded by the data 
acquisition computer) and volumetric flow rate. In the 
general case, for example in spontaneous respiration, the two 
integrals A1 and A2 can be evaluated for each inspiration. 
To first order, it is assumed that the alveolar concentration 
does not change during exhalation, so that the end-
inspiratory Pi(t) becomes the end tidal PET for the next 
breath. The kinetics of gas dilution in the alveolus are 
therefore represented during the pulse of 
17O2 as a series of 
steps, one step for each breath, with the time course during 
inspiration represented by equations (A1) and (A2) (applied 62    The Open Biomedical Engineering Journal, 2008, Volume 2  Baumgardner et al. 
recursively) and plateaus during exhalation. After the pulse 
of 
17O2, the kinetics of alveolar washout are described by a 
similar series of decreasing steps. Finally, for the healthy 
lung it is commonly assumed that the arterial concentration 
is equal to the alveolar concentration at all times [26]. 
  For controlled ventilation in an anesthetized experimental 
subject, the target inspiratory flow is set to a constant value 
throughout inhalation, with the constant inspiratory flow 
determined by the software to achieve a specified tidal 
volume. The peristaltic pump, however, takes about 1 second 
to accelerate from a speed of zero to the target speed. For 
typical large animal subjects, therefore, the ventilator 
delivers the deadspace volume during the acceleration 
period, and at all times after that the inspiratory flow rate is 
constant at W ml/sec. The alveolar gas concentration 
changes in inspiration are therefore given simply by: 
        (A3) 
where PI is the constant inspired partial pressure in the 
current inspiration and PET is the end-tidal partial pressure in 
the last exhalation. This simplified equation is again applied 
recursively to describe the kinetics of gas dilution in the 
alveolus as a series of steps.  
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